Trial Profile

Phase 2b, Double-blind, Placebo-controlled Efficacy Challenge Study With a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Shigellosis vaccine (Primary)
Indications Bacillary dysentery
Focus Pharmacodynamics; Proof of concept
Sponsors LimmaTech Biologics

Most Recent Events

09 Oct 2023 According to a -LimmaTech Biologics AG media release, the company expects to announce preliminary results from this clinical trial in the second half of 2023.
23 Aug 2017 Status changed from active, no longer recruiting to completed.
21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Aug 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com